BRPI0713826A2 - Derivados dq quinuclidina como antagonistas dos receptores muscarinicos m3 - Google Patents
Derivados dq quinuclidina como antagonistas dos receptores muscarinicos m3Info
- Publication number
- BRPI0713826A2 BRPI0713826A2 BRPI0713826A BRPI0713826A2 BR PI0713826 A2 BRPI0713826 A2 BR PI0713826A2 BR PI0713826 A BRPI0713826 A BR PI0713826A BR PI0713826 A2 BRPI0713826 A2 BR PI0713826A2
- Authority
- BR
- Brazil
- Prior art keywords
- receptor antagonists
- muscarinic receptor
- quinuclidine derivatives
- quinuclidine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06117883A EP1882691A1 (en) | 2006-07-26 | 2006-07-26 | Quinuclidine derivatives as M3 antagonists |
PCT/EP2007/057585 WO2008012290A2 (en) | 2006-07-26 | 2007-07-23 | Quinuclidine derivatives as m3 antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0713826A2 true BRPI0713826A2 (pt) | 2015-05-12 |
Family
ID=37890216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0713826 BRPI0713826A2 (pt) | 2006-07-26 | 2007-07-23 | Derivados dq quinuclidina como antagonistas dos receptores muscarinicos m3 |
Country Status (16)
Country | Link |
---|---|
US (1) | US7838534B2 (pt) |
EP (2) | EP1882691A1 (pt) |
JP (1) | JP5331688B2 (pt) |
KR (1) | KR20090033443A (pt) |
CN (1) | CN101490049A (pt) |
AR (1) | AR062104A1 (pt) |
AU (1) | AU2007278231B2 (pt) |
BR (1) | BRPI0713826A2 (pt) |
CA (1) | CA2658649A1 (pt) |
CL (1) | CL2007002159A1 (pt) |
EA (1) | EA017698B1 (pt) |
MX (1) | MX2009000999A (pt) |
PE (1) | PE20080407A1 (pt) |
TW (1) | TW200817398A (pt) |
WO (1) | WO2008012290A2 (pt) |
ZA (1) | ZA200901124B (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20020719A1 (es) | 2000-12-22 | 2002-10-11 | Almirall Prodesfarma Ag | Derivados de carbamato de quinuclidina como agentes antimuscarinicos m3 |
ES2246170B1 (es) * | 2004-07-29 | 2007-04-01 | Almirall Prodesfarma, S.A. | Nuevo procedimiento para preparar derivados de carbamato de quinuclidinio. |
EP2080507A1 (en) * | 2008-01-15 | 2009-07-22 | CHIESI FARMACEUTICI S.p.A. | Pharmaceutical formulations comprising an anticholinergic drug |
EP2080523A1 (en) | 2008-01-15 | 2009-07-22 | CHIESI FARMACEUTICI S.p.A. | Compositions comprising an antimuscarinic and a long-acting beta-agonist |
EP2080508A1 (en) | 2008-01-15 | 2009-07-22 | CHIESI FARMACEUTICI S.p.A. | Dry powder formulation comprising an anticholinergic drug |
EP2154136A1 (en) * | 2008-08-08 | 2010-02-17 | CHIESI FARMACEUTICI S.p.A. | Quinuclidine carbonate derivatives and medicinal compositions thereof |
EP2206712A1 (en) * | 2008-12-23 | 2010-07-14 | CHIESI FARMACEUTICI S.p.A. | "Alkaloid aminoester derivatives and medicinal composition thereof" |
EP2585458B1 (en) | 2010-06-22 | 2015-01-07 | Chiesi Farmaceutici S.p.A. | Alkaloid aminoester derivatives and medicinal compositions thereof |
CN102946868B (zh) * | 2010-06-22 | 2014-10-29 | 奇斯药制品公司 | 包含抗毒蕈碱药的干粉制剂 |
CA2803416A1 (en) * | 2010-06-22 | 2011-12-29 | Chiesi Farmaceutici S.P.A. | Alkaloid aminoester derivatives and medicinal composition thereof |
WO2011161018A1 (en) | 2010-06-22 | 2011-12-29 | Chiesi Farmaceutici S.P.A. | Alkaloid aminoester derivatives and medicinal compositions thereof |
KR20130141534A (ko) | 2010-11-26 | 2013-12-26 | 키에시 파르마슈티시 엣스. 피. 에이. | 글리신 유도체 및 무스카린 수용체 길항제로서의 이들의 용도 |
US20120220557A1 (en) | 2011-02-17 | 2012-08-30 | Chiesi Farmaceutici S.P.A. | Liquid propellant-free formulation comprising an antimuscarinic drug |
CA2834467A1 (en) | 2011-04-29 | 2012-11-01 | Chiesi Farmaceutici S.P.A. | Alkaloid ester and carbamate derivatives and medicinal compositions thereof |
EP2797910B1 (en) | 2011-12-30 | 2015-09-16 | Chiesi Farmaceutici S.p.A. | Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR200400420T4 (tr) * | 2000-06-27 | 2004-03-22 | Laboratorios S.A.L.V.A.T., S.A. | Arilalkilaminlerden türetilmiş karbamatlar. |
PE20020719A1 (es) * | 2000-12-22 | 2002-10-11 | Almirall Prodesfarma Ag | Derivados de carbamato de quinuclidina como agentes antimuscarinicos m3 |
DE10064816A1 (de) * | 2000-12-22 | 2002-06-27 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung eines Anticholinergikums |
KR100944580B1 (ko) * | 2001-12-20 | 2010-02-25 | 치에시 파마슈티시 에스.피.아. | 1-알킬-1-아조니아비시클로[2.2.2]옥탄 카르바메이트유도체 및 이의 무스카린 수용체 길항제로서의 용도 |
ES2203327B1 (es) * | 2002-06-21 | 2005-06-16 | Almirall Prodesfarma, S.A. | Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen. |
-
2006
- 2006-07-26 EP EP06117883A patent/EP1882691A1/en not_active Withdrawn
-
2007
- 2007-07-23 CA CA002658649A patent/CA2658649A1/en not_active Abandoned
- 2007-07-23 KR KR1020097000875A patent/KR20090033443A/ko active IP Right Grant
- 2007-07-23 EA EA200970158A patent/EA017698B1/ru not_active IP Right Cessation
- 2007-07-23 JP JP2009521244A patent/JP5331688B2/ja not_active Expired - Fee Related
- 2007-07-23 WO PCT/EP2007/057585 patent/WO2008012290A2/en active Application Filing
- 2007-07-23 MX MX2009000999A patent/MX2009000999A/es active IP Right Grant
- 2007-07-23 BR BRPI0713826 patent/BRPI0713826A2/pt not_active IP Right Cessation
- 2007-07-23 ZA ZA200901124A patent/ZA200901124B/xx unknown
- 2007-07-23 EP EP07787828A patent/EP2049533A2/en not_active Withdrawn
- 2007-07-23 AU AU2007278231A patent/AU2007278231B2/en not_active Ceased
- 2007-07-23 CN CNA2007800275977A patent/CN101490049A/zh active Pending
- 2007-07-24 CL CL2007002159A patent/CL2007002159A1/es unknown
- 2007-07-24 PE PE2007000959A patent/PE20080407A1/es not_active Application Discontinuation
- 2007-07-25 TW TW096127025A patent/TW200817398A/zh unknown
- 2007-07-25 US US11/881,146 patent/US7838534B2/en not_active Expired - Fee Related
- 2007-07-25 AR ARP070103307A patent/AR062104A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2007278231B2 (en) | 2012-08-16 |
WO2008012290A2 (en) | 2008-01-31 |
US20080039493A1 (en) | 2008-02-14 |
EA200970158A1 (ru) | 2009-06-30 |
MX2009000999A (es) | 2009-04-15 |
EP2049533A2 (en) | 2009-04-22 |
WO2008012290A3 (en) | 2008-03-13 |
JP5331688B2 (ja) | 2013-10-30 |
KR20090033443A (ko) | 2009-04-03 |
JP2009544659A (ja) | 2009-12-17 |
AR062104A1 (es) | 2008-10-15 |
CA2658649A1 (en) | 2008-01-31 |
AU2007278231A1 (en) | 2008-01-31 |
EA017698B1 (ru) | 2013-02-28 |
EP1882691A1 (en) | 2008-01-30 |
CN101490049A (zh) | 2009-07-22 |
PE20080407A1 (es) | 2008-06-17 |
CL2007002159A1 (es) | 2008-01-04 |
TW200817398A (en) | 2008-04-16 |
ZA200901124B (en) | 2010-05-26 |
US7838534B2 (en) | 2010-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0713826A2 (pt) | Derivados dq quinuclidina como antagonistas dos receptores muscarinicos m3 | |
BRPI0812981A2 (pt) | Derivados de piperidina úteis como antagonistas dos receptores de orexina | |
BRPI0821141A2 (pt) | Derivados de heteroarila como antagonistas do receptor de orexina | |
ATE555111T1 (de) | Chinuclidinol-derivate als muscarinrezeptor- antagonisten | |
ATE540942T1 (de) | Imidazolderivate als ccr2-rezeptor-antagonisten | |
BRPI0919844A2 (pt) | compostos de azaindazol como antagonistas do receptor ccr1 | |
BRPI0817245A2 (pt) | Derivados e quinolina como antagonistas receptores de 5ht5a | |
DK2081951T3 (da) | Progesteron-receptorantagonister | |
BRPI0717937A2 (pt) | Compostos de pirazona como antagonistas do receptor mineralocorticóide | |
ATE509022T1 (de) | Nikotin-acetylcholin-rezeptorsubtyp-selektive diazabicycloalkanamide | |
BRPI0909157A2 (pt) | compostos heterocíclicos como antagonistas de receptores de adenosina | |
ES2385606T8 (es) | Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina | |
BRPI0810462A2 (pt) | Derivados de quinolina-carboxamida como antagonistas de p2y12 | |
BRPI0717023A2 (pt) | Tiazol pirazolopirimidina como antagonistas do receptor de crf1 | |
BRPI0815948A2 (pt) | "compostos heterocíclicos como antagonistas de receptorncrth2" | |
DK2252581T3 (da) | Kappa-selektiv opioidreceptorantagonist | |
BRPI0815797A2 (pt) | Compostos 8-azabiciclo[3.2.1]octil-2-hidroxibanzamida como antagonistas de receptor opióide mu | |
BRPI0718494A2 (pt) | Derivado de fenilsulfamoil benzamida como antagonistas de bradicinina | |
BRPI0814767A2 (pt) | Derivados de monoamida como antagonistas do receptor de orexina | |
BRPI0817061A2 (pt) | Derivados de pirrolidinilalquilisoquinolinona e -isoindolinona como antagonistas de histamina-3 | |
BRPI0807615A2 (pt) | compostos de difenilmetil amônico quaternário úteis como antagonistas de receptor muscarínico | |
BRPI0718436A2 (pt) | Novos derivados de benzamida como antagonistas da bradicina | |
BRPI0918985A2 (pt) | derivados de benzo[d]isoxazol-3-il-piperazina úteis como moduladores dos receptores d3 de dopamina | |
IL199971A0 (en) | Heterocyclic derivatives as m3 muscarinic receptors | |
BRPI0822693A2 (pt) | Derivados de quinuclidina como antagonistas do receptor muscarínico m3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |